Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,088 | -17,537 | -8,793 | -28,466 | -20,579 |
| Depreciation Amortization | 33 | 23 | 11 | 40 | 177 |
| Other Working Capital | -651 | 338 | -37 | -28 | -319 |
| Other Operating Activity | 2,836 | 1,875 | 920 | 3,158 | 2,258 |
| Operating Cash Flow | $-22,870 | $-15,301 | $-7,899 | $-25,296 | $-18,463 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -63 | -63 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -776 |
| Investing Cash Flow | $N/A | $0 | $0 | $-63 | $-839 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 147 | 147 | 104 | 76,954 | 76,918 |
| Financing Cash Flow | $147 | $147 | $104 | $76,954 | $76,918 |
| Beginning Cash Position | 75,807 | 75,807 | 75,807 | 24,212 | 24,212 |
| End Cash Position | 53,084 | 60,653 | 68,012 | 75,807 | 81,828 |
| Net Cash Flow | $-22,723 | $-15,154 | $-7,795 | $51,595 | $57,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,870 | -15,301 | -7,899 | -25,296 | -18,463 |
| Capital Expenditure | N/A | 0 | 0 | -63 | -63 |
| Free Cash Flow | -22,870 | -15,301 | -7,899 | -25,359 | -18,526 |